WHO ICTRP trial

A real-world study of rationalization of patient-controlled intravenous…

ChiCTR2500100997 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500100997
Public title A real-world study of rationalization of patient-controlled intravenous analgesia after general anesthesia
Scientific title A real-world study of rationalization of patient-controlled intravenous analgesia after general anesthesia
Primary sponsor Yichang Central People's Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Countries China
Conditions Effect of intrathecal morphine on the quality of recovery after pulmonary surgery
Interventions Control Group (Nalbuphine 0.4mg/ml combined with sufentanil 1µg/ml+ ondansetron 8mg):None;Experimental Group(Hydromorifone 10mg+ esamamine 50mg+ Nalbuphine 40mg+ obebe 8mg+ betamethasone 20mg+ butorphine tartrate injection 2mg to 0.9%…
Registration date Apr 17, 2025
Target size Control Group (Nalbuphine 0.4mg/ml combined with sufentanil 1µg/ml+ ondansetron…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations